Business
Strong Q3 Results: The Oncology Institute Stock Soars
The Oncology Institute, a prominent value-based community oncology group in the United States, announced its financial results for the third quarter (Q3) and nine months...
JanOne Inc Stock Surges 117% Despite Lack of News
In a surprising turn of events, JanOne Inc, a prominent biotechnology firm specializing in the development of treatments for severe pain conditions, witnessed a notable...
The Honest Company Reports Strong Q3 Results with 2% Revenue Growth, Stock Shines
The Honest Company, a digitally-native consumer products company focused on producing clean and sustainably-designed items across various categories including baby care, beauty, personal care, wellness,...
Fitell Corp Stock Surges on Fiscal 2023 Financial Results
Fitell Corp, a prominent online retailer specializing in gym and fitness equipment in Australia, unveiled its annual financial results for the fiscal year ending June...
Assertio Holdings Releases Strong Q3 Results, But Stocks Slide
Assertio Holdings, a specialty pharmaceutical company known for its acquisition, commercialization, and development of safe and effective therapies, released its financial results for the third...
Acutus Medical Shines in Q3 Results with 44% Increase in Revenue, Stock Dips
In a report released yesterday, Acutus Medical, a prominent player in the field of arrhythmia management, disclosed its financial results for the third quarter (Q3)...
Wearable Devices’ Public Offering Triggers Stock Decline, Eyes $2M Funding Boos
Wearable Devices, a leading technology company specializing in AI-powered touchless sensing wearables, has unveiled details of its upcoming public offering, anticipating gross proceeds of approximately...
WideOpenWest Delivers Solid Q3 Results, Stock Still Falls
WideOpenWest Inc (WOW), a prominent broadband provider, unveiled its financial results for the third quarter (Q3)ending September 30, 2023, on November 8, 2023. The company...
Ikena Oncology Reports Q3 Results and Data from Phase I Clinical Trial, Stock Dips
Ikena Oncology, a pioneering targeted oncology company revolutionizing patient-directed cancer treatment, unveiled its earnings results for the third quarter (Q3) and nine months ending September...
Atara Biotherapeutics’ EMBOLD Study Fails to Meet Primary Endpoint in Multiple Sclerosis Trial, Stock Falls
Atara Biotherapeutics, a leading biotechnology company, witnessed a sharp decline in its stock value today following the release of disappointing results from its Phase 2...